LIBERTY randomized withdrawal study: relugolix combination therapy for heavy menstrual bleeding associated with uterine fibroids is a research paper published in American Journal of Obstetrics and Gynecology (2023). On theSindex it has a DataRank of 0.962. It has been cited 22 times, with 19 citing works in its 1-hop citation network.
Scored on demand from live citation data
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.470
From this paper's citation signal
Citation Network Contribution
0.492
From 13 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 19 citers.
National Institutes of Health
Grant: 9,790,562 B2
National Institutes of Health
Grant: R01 ES 028615-01
National Institutes of Health
Grant: R01 HD 094378
National Institutes of Health
Grant: R01 HD 094380
National Institutes of Health
Grant: R01 HD 10036701
National Institutes of Health
Grant: R01HD 087417
National Institutes of Health
Grant: U54 MD 007602
NIEHS NIH HHS
Grant: R01 ES028615
NIAID NIH HHS
Grant: R01 AI036701
Myovant Sciences
MeSH Terms
Keywords